Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nevin C Baker

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Circulation|October 8, 2014
Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting about vorapaxarNevin C Baker, Michael J Lipinski, Thibault Lhermusier, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 20, 2015
Radial versus femoral access in patients presenting with acute coronary syndrome in the post-matrix era: Still one size does not fit allRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Spine|December 28, 2013
Re: Fineberg SJ, Oglesby M, Patel AA, et al. Incidence and mortality of perioperative cardiac events in cervical spine surgery. Spine 2013;38:1268–74Armando Romero Perez, Ricardo O Escárcega, Nevin C Baker, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 3, 2014
Safety of eptifibatide when added to bivalirudin during ST-segment elevation myocardial infarctionNevin C Baker, Ricardo O Escarcega, Marco A Magalhaes, et al.
Journal of the American Society of Hypertension : JASH|December 22, 2015
Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trialCharan Yerasi, Nevin C Baker, Anil K Jonnalagadda, et al.
The American Journal of Cardiology|March 1, 2014
Definitions of periprocedural myocardial infarction as surrogates for catheterization laboratory quality or clinical trial end pointsNevin C Baker, Michael J Lipinski, Ricardo O Escarcega, et al.
International Journal of Cardiology|April 22, 2014
Mortality in patients requiring pacemaker implantation following transcatheter aortic valve replacement: insights from a systematic review and meta-analysisRicardo O Escárcega, Marco A Magalhaes, Michael J Lipinski, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-AnalysisMichael J Lipinski, Ricardo O Escarcega, Nevin C Baker, et al.
Expert Opinion on Drug Delivery|February 19, 2014
Current application and bioavailability of drug-eluting stentsRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Journal of Interventional Cardiology|January 6, 2016
Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative AnalysisNevin C Baker, Ricardo O Escarcega, Michael J Lipinski, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Circulation|October 8, 2014
Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting about vorapaxarNevin C Baker, Michael J Lipinski, Thibault Lhermusier, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 20, 2015
Radial versus femoral access in patients presenting with acute coronary syndrome in the post-matrix era: Still one size does not fit allRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Spine|December 28, 2013
Re: Fineberg SJ, Oglesby M, Patel AA, et al. Incidence and mortality of perioperative cardiac events in cervical spine surgery. Spine 2013;38:1268–74Armando Romero Perez, Ricardo O Escárcega, Nevin C Baker, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 3, 2014
Safety of eptifibatide when added to bivalirudin during ST-segment elevation myocardial infarctionNevin C Baker, Ricardo O Escarcega, Marco A Magalhaes, et al.
Journal of the American Society of Hypertension : JASH|December 22, 2015
Assessment of hypertension control and clinical course of patients excluded from the SYMPLICITY HTN-3 trialCharan Yerasi, Nevin C Baker, Anil K Jonnalagadda, et al.
The American Journal of Cardiology|March 1, 2014
Definitions of periprocedural myocardial infarction as surrogates for catheterization laboratory quality or clinical trial end pointsNevin C Baker, Michael J Lipinski, Ricardo O Escarcega, et al.
International Journal of Cardiology|April 22, 2014
Mortality in patients requiring pacemaker implantation following transcatheter aortic valve replacement: insights from a systematic review and meta-analysisRicardo O Escárcega, Marco A Magalhaes, Michael J Lipinski, et al.
JACC. Cardiovascular Interventions|January 15, 2016
Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-AnalysisMichael J Lipinski, Ricardo O Escarcega, Nevin C Baker, et al.
Expert Opinion on Drug Delivery|February 19, 2014
Current application and bioavailability of drug-eluting stentsRicardo O Escárcega, Nevin C Baker, Michael J Lipinski, et al.
Journal of Interventional Cardiology|January 6, 2016
Active Versus Passive Anchoring Vascular Closure Devices Following Percutaneous Coronary Intervention: A Safety and Efficacy Comparative AnalysisNevin C Baker, Ricardo O Escarcega, Michael J Lipinski, et al.
Pageof 5